Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 5, 2014
Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance
Amy Haseley Thorne, Walter H Meisen, Luke Russell, et al.
Cancer Research
|
January 22, 2015
Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance
Valery Adorno-Cruz, Golam Kibria, Xia Liu, et al.
Journal of Neuro-Oncology
|
December 29, 2022
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449
Andrew E Sloan, Charles J Nock, Xiaobu Ye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2003
High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas
Sridharan Gururangan, Colleen McLaughlin, Jennifer Quinn, et al.
Research Square
|
April 17, 2026
Targeting Tumour Microtubes to Disrupt Glioma Networks
Jeremy Rich, Tengfei Huang, Po Zhang, et al.
Neuro-Oncology Advances
|
December 1, 2022
Glioma stem cells activate platelets by plasma-independent thrombin production to promote glioblastoma tumorigenesis
Anthony R Sloan, Christine Lee-Poturalski, Harry C Hoffman, et al.
EMBO Molecular Medicine
|
July 15, 2024
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells
Jeremy Rich, Melanie Bennaroch, Laura Notel, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
AAV Kills Dividing Cells by Depleting PARP1 and Other DNA Damage Response Proteins
Sasha Friese, Junjie Zai, Grace Luzbetak, et al.
Journal of Neuro-Oncology
|
December 3, 2003
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors
John H Sampson, Gamal Akabani, Gary E Archer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2005
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma
Jennifer A Quinn, Annick Desjardins, Jon Weingart, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 5, 2014
Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance
Amy Haseley Thorne, Walter H Meisen, Luke Russell, et al.
Cancer Research
|
January 22, 2015
Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance
Valery Adorno-Cruz, Golam Kibria, Xia Liu, et al.
Journal of Neuro-Oncology
|
December 29, 2022
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449
Andrew E Sloan, Charles J Nock, Xiaobu Ye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2003
High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas
Sridharan Gururangan, Colleen McLaughlin, Jennifer Quinn, et al.
Research Square
|
April 17, 2026
Targeting Tumour Microtubes to Disrupt Glioma Networks
Jeremy Rich, Tengfei Huang, Po Zhang, et al.
Neuro-Oncology Advances
|
December 1, 2022
Glioma stem cells activate platelets by plasma-independent thrombin production to promote glioblastoma tumorigenesis
Anthony R Sloan, Christine Lee-Poturalski, Harry C Hoffman, et al.
EMBO Molecular Medicine
|
July 15, 2024
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells
Jeremy Rich, Melanie Bennaroch, Laura Notel, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
AAV Kills Dividing Cells by Depleting PARP1 and Other DNA Damage Response Proteins
Sasha Friese, Junjie Zai, Grace Luzbetak, et al.
Journal of Neuro-Oncology
|
December 3, 2003
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors
John H Sampson, Gamal Akabani, Gary E Archer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2005
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma
Jennifer A Quinn, Annick Desjardins, Jon Weingart, et al.
Page
of 5